|
ARCN1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.07460000020998E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33159999973864E-07 |
| Normal-vs-Stage2 |
5.548000E-02 |
| Normal-vs-Stage3 |
3.487400E-01 |
| Normal-vs-Stage4 |
9.831500E-02 |
| Stage1-vs-Stage2 |
3.367600E-01 |
| Stage1-vs-Stage3 |
1.689000E-01 |
| Stage1-vs-Stage4 |
5.965200E-01 |
| Stage2-vs-Stage3 |
6.098200E-01 |
| Stage2-vs-Stage4 |
8.637600E-01 |
| Stage3-vs-Stage4 |
6.238600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.09059999983974E-07 |
| Normal-vs-AfricanAmerican |
9.807500E-04 |
| Normal-vs-Asian |
4.020400E-01 |
| Caucasian-vs-AfricanAmerican |
5.693800E-01 |
| Caucasian-vs-Asian |
6.421000E-01 |
| AfricanAmerican-vs-Asian |
7.794800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.90119969451553E-10 |
| Normal-vs-Female |
5.899800E-01 |
| Male-vs-Female |
1.646280E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.358200E-03 |
| Normal-vs-Extreme_Weight |
1.18779999946916E-07 |
| Normal-vs-Obese |
4.738400E-02 |
| Normal-vs-Extreme_Obese |
1.73052999999923E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.559200E-01 |
| Normal_Weight-vs-Obese |
3.383200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.797400E-01 |
| Extreme_Weight-vs-Obese |
3.862100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.871600E-01 |
| Obese-vs-Extreme_Obese |
1.287970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.482000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.554100E-04 |
| Normal-vs-Age(61-80Yrs) |
5.19689957734215E-10 |
| Normal-vs-Age(81-100Yrs) |
5.995500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.105570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.622400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.886300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.642200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.429800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.272000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85269999342097E-09 |
| Normal-VS-Type2 PRCC |
2.44029999999507E-05 |
| Normal-VS-KIRP CIMP |
8.198400E-02 |
| Normal-VS-Unclassified PRCC |
1.005020E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.640000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.619400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.089800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.353610E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.148200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.497400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.215340E-04 |
| Normal-vs-N1 |
8.532200E-01 |
| Normal-vs-N2 |
1.482040E-02 |
| N0-vs-N1 |
1.139190E-01 |
| N0-vs-N2 |
9.062200E-01 |
| N1-vs-N2 |
4.507200E-01 |
|
|
